Wagner Votes for Legislation to Lower Prescription Drug Costs and Protect Access to Lifesaving Cures
Washington, D.C. — Congresswoman Ann Wagner (R-MO) released the following statement after she voted for H.R. 19, the Lower Costs, More Cures Act, bipartisan legislation that would lower drug costs and help patients:
“Americans spend too much on prescription medications, and it is up to Congress to fix the problems that are driving these burdensome medical costs. I was proud to vote for legislation that lowers costs at the pharmacy counter for all Americans and makes healthcare more affordable.
“The Lower Costs, More Cures Act protects patient access to new lifesaving cures and medicines. It creates transparency in the prescribing process by ensuring that patients can find out the costs of their medications at the doctor’s office before they reach the pharmacy counter. This bill caps out-of-pocket costs for seniors, lowers how much families pay for insulin, brings generic drugs to market faster, and provides incentives to provide rebates to seniors at the pharmacy counter. The Lower Costs, More Cures Act stops drug companies from taking advantage of Americans. It can pass the Senate and be signed into law by the President. Every provision is bipartisan, and we owe it to all Americans to pass legislation that can become law. We cannot settle for Speaker Pelosi’s legislation that is dead on arrival in the Senate and would blackmail innovators, end America’s fast and comprehensive access to new and existing medicines, do nothing to protect Medicare from insolvency, and prevent cures from being developed.”